SondosZayedMD Profile Banner
Sondos Zayed Profile
Sondos Zayed

@SondosZayedMD

Followers
347
Following
733
Media
16
Statuses
220

MD | Radiation Oncologist | The Ottawa Hospital | #WomenWhoCurie | Public Health & Gender Equity advocate | Tweets = Own views | 2023 #WXNTop100

Ontario, Canada
Joined August 2019
Don't wanna be here? Send us removal request.
@SondosZayedMD
Sondos Zayed
5 days
RT @KrishanJethwa: 🚨ACCORD Trial🚨. Resected Extrahepatic CCA or Gallbladder CA. 🔍Randomized. Adjuvant CRT + Camrelizumab.vs.Observation. 🔥W….
0
45
0
@SondosZayedMD
Sondos Zayed
1 month
RT @ozdogan_md: 🚨 Exercise is no longer optional, it is essential!. One of the most impactful studies at #ASCO25. 🏃‍♂️ The #CHALLENGE trial….
0
99
0
@SondosZayedMD
Sondos Zayed
1 month
RT @PDBrownOnc: 🚨Update Randomized Trial: Significantly Better KPS & Cognitive Function with SRS compared to HA-WBRT for 5-20 brain mets 🚨🚨….
0
31
0
@SondosZayedMD
Sondos Zayed
1 month
RT @DrNicolasHart: A standing ovation for #CHALLENGE trial at #ASCO25 - first in world to definitively show exercise reduces recurrence and….
0
110
0
@SondosZayedMD
Sondos Zayed
1 month
RT @JAMAOnc: Most viewed this week from @JAMAOnc: . Viewpoint discusses how "skimming the median" can exaggerate survival gains in clinical….
0
6
0
@SondosZayedMD
Sondos Zayed
1 month
RT @KrishanJethwa: 🚨SPRING-01🚨. 🔍Locally Advanced Rectal Cancer. RCT: .25 Gy x 5 ➡️ CAPOX +- Sintilimab. 🔥+ Sintilimab demonstrated:. ✅⬆️pC….
0
33
0
@SondosZayedMD
Sondos Zayed
1 month
RT @SuyogCancer: What if this was a drug ?🙂 . 🆕 NEJM | June 2025.🎯 CHALLENGE Trial: Structured exercise after adjuvant chemo in colon can….
0
129
0
@SondosZayedMD
Sondos Zayed
2 months
RT @JAMAOnc: Viewpoint discusses how "skimming the median" can exaggerate survival gains in clinical trials, underscoring the need to criti….
0
73
0
@SondosZayedMD
Sondos Zayed
4 months
RT @JoeChangMD: For patients with esophageal ca who achieved complete clinical response after chemo/RT, esophagectomy vs surveillance? Phas….
0
12
0
@SondosZayedMD
Sondos Zayed
4 months
RT @MikeChuongMD: Our critical review of contemporary radiation therapy for locally advanced #pancreaticcancer is in press @IJROBP 🙌. @JonA….
0
44
0
@SondosZayedMD
Sondos Zayed
5 months
RT @gusviani: 🚨 Hippocampal-Avoidance PCI: Game-Changer or Cognitive Mirage? 🚨 @OncoAlert .🔎 Objective.•Evaluate the impact of HA-PCI on se….
0
26
0
@SondosZayedMD
Sondos Zayed
5 months
RT @OscarTahuahua: Management of Locally Advanced Rectal Cancer: ASCO Guideline | @JCO_ASCO . .
0
97
0
@SondosZayedMD
Sondos Zayed
5 months
RT @NiuSanford: We also consider SBRT for oligoprogression in HCC b/c:. -high local control.-usually low toxicity.-allows pt to stay on 1st….
0
23
0
@SondosZayedMD
Sondos Zayed
5 months
RT @NicholasZaorsky: How to update publications and abstracts in your CV. These are the most time-efficient ways to keep your publications….
0
26
0
@SondosZayedMD
Sondos Zayed
5 months
RT @dr_yakupergun: Meta‐analysis of randomized controlled trials of external‐beam radiation versus TACE for HCC. Pooled analysis of 3 RCTs….
0
55
0
@SondosZayedMD
Sondos Zayed
6 months
RT @NiuSanford: Yes, I made a similar pt in my talk re: TOPGEAR. Differences in treatment effect by primary tumor location. .
0
11
0
@SondosZayedMD
Sondos Zayed
6 months
RT @MyriamChalabi: Long awaited practice-changing results from ph 3 CM8HW now out in @TheLancet. Nivo/ipi sign better than nivo mono in dMM….
0
38
0
@SondosZayedMD
Sondos Zayed
6 months
Novel primary percutaneous stenting method for hilar CC presented by Dr Koerkamp @ASCO #GI25 .Website describing technique below so your interventionalist can implement it tomorrow! Promising Ph2 results with 0% cholangitis. RCT ongoing in Netherlands.
0
0
4
@SondosZayedMD
Sondos Zayed
6 months
RT @ryanhuey: Dr. Koerkamp emphasizes that biliary drainage is key for BTC (and makes the case for percutaneous stenting). #GI25 https://t.….
0
2
0
@SondosZayedMD
Sondos Zayed
6 months
RT @ryanhuey: Dr. Dotan reminds us of the role of geriatric assessment to reduce chemo toxicity in PDAC. I suspect the surgeons are better….
0
6
0